Geron | Omløpsmidler



Current Assets Endring Dato
Amgen USD 29.03B 2.26B 2024-12
Bio Techne USD 634.64M 13.93M 2024-12
Cassava Sciences USD 136.53M 66.02M 2024-12
Cytokinetics USD 1.11B 89.34M 2024-12
Exelixis USD 1.47B 82.14M 2025-01
Genmab DKK 27.85B 4.16B 2024-12
Geron USD 490.99M 92.94M 2024-12
Gilead Sciences USD 19.17B 4.39B 2024-12
Incyte USD 3.24B 430.32M 2024-12
MacroGenics USD 217.49M 4.71M 2024-12
Novartis USD 29.7B 1.56B 2024-12



Geron Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.